High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.
<h4>Background</h4>MicroRNAs (miRNAs) are known to regulate many biological processes and their dysregulation has been associated with a variety of diseases including Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). The recent discovery of stable and reproducible miRNA in pla...
Guardado en:
Autores principales: | Ekua W Brenu, Kevin J Ashton, Jana Batovska, Donald R Staines, Sonya M Marshall-Gradisnik |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/87761deeb59f48fa98a0c565bc592825 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Postulated vasoactive neuropeptide immunopathology affecting the blood&ndash;brain/blood&ndash;spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?
por: Sonya Marshall-Gradisnik, et al.
Publicado: (2008) -
Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP<sub>2</sub> in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Stanley Du Preez, et al.
Publicado: (2021) -
Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?
por: Donald R Staines, et al.
Publicado: (2009) -
Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients
por: Nguyen,T., et al.
Publicado: (2016) -
Back to the Future? Immunoglobulin Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Helen Brownlie, et al.
Publicado: (2021)